HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human monocytic ehrlichiosis in a renal transplant patient.

Abstract
Human ehrlichiosis is an emerging pathogen in immunocompromised patients, potentially leading to increased morbidity compared to immunocompetent patients. A high index of suspicion is imperative and early treatment with doxycycline can be life-saving. We report the case of an immunosuppressed renal transplant patient who was diagnosed with human monocytic ehrlichiosis and successfully treated with doxycycline.
AuthorsCasey Cotant, Jason F Okulicz, Barton Brezina, Daniel J Riley, Nicholas G Conger
JournalScandinavian journal of infectious diseases (Scand J Infect Dis) Vol. 38 Issue 8 Pg. 699-702 ( 2006) ISSN: 0036-5548 [Print] England
PMID16857619 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Doxycycline
Topics
  • Doxycycline (therapeutic use)
  • Ehrlichiosis (drug therapy, immunology)
  • Humans
  • Immunosuppression Therapy (adverse effects)
  • Kidney Transplantation (immunology)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: